Search Ontology:
ChEBI
avanafil
- Term ID
- CHEBI:66876
- Synonyms
-
- (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide
- 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
- avanafil
- Stendra
- Definition
- A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid with the amino group of pyrimidin-2-ylmethylamine. Used for treatment of erectile dysfunction.
- References
-
- CAS:330784-47-9
- Drug_Central:4305
- KEGG:D03217
- PMID:18197727
- PMID:18491987
- PMID:20637970
- PMID:20939743
- PMID:21745238
- PMID:21905762
- PMID:22087063
- PMID:22248153
- PMID:22384456
- PMID:22448738
- PMID:22704456
- PMID:22759639
- PMID:22788525
- Patent:EP1366760
- Patent:US6403597
- Reaxys:11746013
- Wikipedia:Avanafil
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from avanafil
Phenotype where environments contain avanafil
Phenotype modified by environments containing avanafil
Human Disease Model